-
![Prodrugs of 2-(3,5-Dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone](/abs-image/US/2024/03/14/US20240083925A1/abs.jpg.150x150.jpg)
公开(公告)号：US20240083925A1
公开(公告)日：2024-03-14
申请号：US18267946
申请日：2021-12-16
Applicant: UCB Biopharma SRL
Inventor： Ali Ates , Celal Ates , Laurent Provins
IPC: C07F9/6558 , C07D401/06
CPC classification number: C07F9/65583 , C07D401/06
Abstract: The present invention relates to a prodrug of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone, which prodrug is represented by formula (II).
Search Results
1
records
(took 0.011 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
